Stay updated on LN-144 Clinical Trial in Metastatic Melanoma

Sign up to get notified when there's something new on the LN-144 Clinical Trial in Metastatic Melanoma page.
Latest website image capture
Clouds background image

Latest updates to the LN-144 Clinical Trial in Metastatic Melanoma page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2, and removed the government funding lapse notice and Revision: v3.4.1 entry.
    Difference
    0.3%
    Check dated 2026-02-11T02:28:26.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about government funding status and operating status was added, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-03T23:20:54.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows a glossary toggle and adds explicit data fields for Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. It also removes the estimated versions of Results First Posted and Last Update Posted, and updates the No FEAR Act data label and the revision history from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-27T21:08:55.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    Expanded the study's Locations section to include numerous US state sites and international locations, broadening where eligible patients can enroll. The update also removes the HHS Vulnerability Disclosure entry and several previously listed locations.
    Difference
    2%
    Check dated 2025-12-22T23:49:36.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Results posted on 2025-12-09 for NCT02360579 with 220 participants and updated efficacy endpoints (ORR, DOR, DCR, PFS, OS) plus related publications. The entry removes the Lifileucel LN-144 without cryopreservation (Gen 1) listing and updates the assessment approach (investigator vs IRC) by cohort.
    Difference
    3%
    Check dated 2025-12-15T20:56:08.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2, replacing the previous Revision: v3.3.1; no user-visible changes to the study details, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T11:57:32.000Z thumbnail image

Stay in the know with updates to LN-144 Clinical Trial in Metastatic Melanoma

Enter your email address, and we'll notify you when there's something new on the LN-144 Clinical Trial in Metastatic Melanoma page.